Results 141 to 150 of about 574 (170)
Some of the next articles are maybe not open access.

Testing for Meldonium, a Doping Agent, in Human Hair

Drug Testing and Analysis
ABSTRACT Meldonium has been developed in the 70s in Latvia and is currently used in a limited number of countries for heart‐related diseases, such as heart attack, failure, or angina pectoris. Due to its metabolic properties (decrease of lactate production, increase of glycogen use, and protective action again ...
Pascal Kintz, , Laurie Gheddar
exaly   +3 more sources

Meldonium residues in milk: A possible scenario for inadvertent doping in sports?

open access: yesDrug Testing and Analysis, 2021
The veterinary drug Emidonol® has been discussed as a possible scenario for inadvertent doping in sports. In a recent study, meldonium concentrations determined in raw milk reached up to 701 ng/ml. If consumed, urine collected post‐ingestion can present meldonium residues and adverse analytical findings in doping controls cannot be excluded.
Sven Guddat   +2 more
exaly   +2 more sources

Meldonium in Treatment of Patients With Myocardial Infarction

Kardiologiia, 2014
Therapy with meldonium belongs to "metabolic direction" which is developing in cardiovascular medicine. Its purpose is restoration of impaired cellular metabolism.
G I, Nechaeva   +2 more
openaire   +2 more sources

Sixty seconds on . . . meldonium

BMJ, 2016
Yes, definitely a double fault for the Russian tennis star. Meldonium (also known as mildronate) is a drug made in Latvia used for treating heart failure, angina, and myocardial infarction. It isn’t licensed in the United States or Europe. We don’t know, but it seems unlikely. She has said that she had magnesium …
openaire   +1 more source

Analytical methods for meldonium determination in urine samples

Analytical Letters, 2020
Here is reported a rapid analytical method for meldonium and other beta blockers (metoprolol, amlodipine, bisoprolol, nebivolol, betaxolol, and carvediol) in urine samples using Fourier transform i...
L. D. Rusu   +4 more
openaire   +1 more source

Efficiency of Meldonium in the Complex Therapy of Acute Coronary Syndrome

Kardiologiia, 2014
We examined 140 patients (mean age 54.8±3.1 years) with ST elevation acute coronary syndrome resulting in Q-wave myocardial infarction of the left ventricle. From the first hours complex therapy of these patients comprised meldonium (1 g/day intravenously for 2 weeks then orally until 1.5 months).
V P, Mikhin   +4 more
openaire   +2 more sources

Electrochemical Sensor for Selective Detection of Meldonium in Urine by Voltammetry

Electroanalysis, 2022
AbstractA highly sensitive electrochemical sensor based on arenediazonium tosylates was designed to detect meldonium in urine. The effect of the concentration of ArN2+OTs− arenediazonium tosylate modifier and various substituents was studied. Basic operating parameters for voltammetric meldonium detection were established and the procedure for urine ...
Olga L. Mezentseva   +5 more
openaire   +1 more source

Chronic cerebrovascular diseases and neuroprotection: the clinical efficacy of meldonium (Mildronat)

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2020
To evaluate the efficacy of meldonium (mildronat) in patients with chronic cerebral vascular disease (CVD).An open comparative study of the clinical efficacy of meldonium (mildronat) in patients with chronic CVD caused by arterial hypertension and atherosclerosis was conducted.
M M, Tanashyan   +5 more
openaire   +2 more sources

Optoelectronical method for identification of meldonium in urine samples

Advanced Topics in Optoelectronics, Microelectronics, and Nanotechnologies IX, 2018
Meldonium is an anti-ischemia drug developed in 1970 by Ivars Kalvins at the USSR Latvia Institute of organic synthesis. Meldonium is reportedly capable of providing clinical benefit for those suffering from heart conditions, such as low blood flow to the heart and angina, as well as neurodegenerative disorders and bronchopulmonary diseases. It appears
Georgeta Marcela Bican   +4 more
openaire   +1 more source

The Ability to use Meldonium as Adaptogen in Winter in Patients With Cardiovascular Disease

Kardiologiia, 2014
Given that the effects of frost can play the role of independent stress factor influencing the course of cardiovascular disease (CVD), it is reasonable to supplementation of drugs that increase the body's resistance to cold stress. Aim: To evaluate the possibility of using meldonium to prevent unwanted seasonal changes in CVD patients in the winter ...
M D, Smirnova   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy